16.00
0.69%
0.11
Handel nachbörslich:
16.00
Finanzdaten der Centessa Pharmaceuticals Plc Adr-Aktie (CNTA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Interest Income/Expense |
1.60%
2.529
|
2.57 | 2.541 | 2.45 | 2.345 |
Operating Income/Loss |
2.59%
-36.09
|
-35.18 | -40.21 | -47.02 | -48.88 |
Income/Loss From Continuing Operations Before Tax |
5.24%
-37.56
|
-35.69 | -41.47 | -48.94 | -50.04 |
Income Tax Expense/Benefit, Deferred |
391.28%
0.434
|
-0.149 | -2.89 | - | - |
Income Tax Expense/Benefit |
57.95%
0.481
|
1.144 | -2.826 | -24.05 | 0.677 |
Income/Loss From Continuing Operations After Tax |
3.28%
-38.05
|
-36.84 | -38.65 | -24.89 | -50.71 |
Net Income/Loss
|
3.28%
-38.05
|
-36.84 | -38.65 | -24.89 | -50.71 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
16,876%
99.89
|
0.5884 | 96.65 | 95.16 | 94.94 |
Diluted Average Shares |
16,876%
99.89
|
0.5884 | 96.65 | 95.16 | 94.94 |
Basic Earnings Per Share |
2.70%
-0.38
|
-0.37 | -0.40 | -0.26 | -0.53 |
Diluted Earnings Per Share |
2.70%
-0.38
|
-0.37 | -0.40 | -0.26 | -0.53 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):